查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498686

全球藥物器材組合產品市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Drug Device Combination Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

全球藥物器材組合產品市場需求預計將從2023年的1,446.6億美元達到2032年近2,967.4億美元的市場規模，2024-2032年研究期間的複合年成長率為8.31%。

藥物器材組合產品是將藥物或生物物質與醫療器材結合以提供治療效果或執行特定治療功能的醫療產品。這些產品旨在提供標靶藥物輸送、增強藥物療效、提高患者依從性，或實現僅使用傳統藥物配方或醫療設備無法實現的新穎治療方式。這些產品涵蓋各種醫療保健干預措施，包括藥物洗脫支架、胰島素幫浦、避孕植入物和吸入裝置。這些創新產品在精準醫療、個人化治療和病患便利性方面具有潛在優勢，推動醫療進步並改善各個治療領域的病患治療效果。

市場動態

對定製藥物和標靶治療的需求不斷成長，推動了創新藥物器材組合產品的開發，這些產品提供精確的藥物傳輸機制並提高患者的依從性。隨著醫療保健提供者和患者尋求更有效、更方便的治療選擇，人們對將藥物的治療益處與醫療設備的精確性和可靠性結合起來的組合產品越來越感興趣。此外，藥物配方技術和設備設計的進步使得能夠開發出適用於從慢性疾病到急性疾病等多種醫療狀況的新型組合產品。此外，管理組合產品的監管舉措和指南，例如 FDA 的組合產品政策和歐盟的醫療器材法規 (MDR)，為製造商提供了一個框架，以應對複雜的監管環境並將創新產品推向市場。

此外，製藥公司、醫療器材製造商和研究機構之間的策略合作推動創新和藥械組合產品市場擴張，促進跨治療領域新藥械組合產品的開發。增加醫療保健支出和對組合產品的報銷支持刺激了研發投資，進一步推動藥物器材組合產品市場的成長。然而，與組合產品開發和報銷挑戰相關的監管障礙和複雜性可能會在未來幾年挑戰藥物器械組合產品市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球藥物器材組合產品市場的每個細分市場進行包容性評估。藥物器械組合產品產業的成長和趨勢為本研究提供了整體方法。

市場區隔

藥品器材組合產品市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 藥物洗脫支架（冠狀動脈藥物洗脫支架、周邊藥物洗脫支架）
  • 輸液幫浦（植入式輸液幫浦、胰島素輸液幫浦、病人自控式止痛幫浦、行動輸液幫浦、容量輸液幫浦、一次性輸液幫浦）
  • 光動力療法
  • 傷口護理組合產品
  • 預灌封注射器（單室預灌封注射器、雙室預灌封注射器、客製預灌封注射器）
  • 藥物洗脫球囊（冠狀動脈藥物洗脫球囊、周邊藥物洗脫球囊）
  • 霧化器
  • 吸入器（藥物粉末吸入器 (DPI)、定量吸入器 (MDI)、軟霧吸入器 (SMI)）
  • 經皮給藥系統（主動經皮系統、被動式經皮系統）
  • 骨科組合產品（骨移植植入物、抗生素骨水泥）
  • 抗菌導管（泌尿導管、心血管導管、其他導管、其他產品）

按申請

  • 心血管疾病
  • 糖尿病
  • 呼吸系統的問題
  • 癌症治療
  • 抗菌應用
  • 其他

按最終用途

  • 醫院和診所
  • 門診手術中心
  • 家庭護理設置
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的藥物器械組合產品市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物器材組合產品市場的主要參與者包括雅培實驗室、艾伯維公司、愛爾康公司、博士健康公司、百特國際公司、拜耳公司、Becton、迪金森公司、波士頓科學公司、葛蘭素史克公司、強生公司Johnson、Kaleo Inc.、Medtronic Plc、Novartis AG、Sinomed、Smith & Nephew Plc、Teleflex Incorporated、Teva Pharmaceutical Industries Ltd. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：藥物器械組合產品 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球藥物器材組合產品市場分析：依產品分類

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 藥物洗脫支架（冠狀動脈藥物洗脫支架、周邊藥物洗脫支架）
  • 輸液幫浦（植入式輸液幫浦、胰島素輸液幫浦、病人自控式止痛幫浦、行動輸液幫浦、容量輸液幫浦、一次性輸液幫浦）
  • 光動力療法
  • 傷口護理組合產品
  • 預灌封注射器（單室預灌封注射器、雙室預灌封注射器、客製預灌封注射器）
  • 藥物洗脫球囊（冠狀動脈藥物洗脫球囊、周邊藥物洗脫球囊）
  • 霧化器
  • 吸入器（藥物粉末吸入器 (DPI)、定量吸入器 (MDI)、軟霧吸入器 (SMI)）
  • 經皮給藥系統（主動經皮系統、被動式經皮系統）
  • 骨科組合產品（骨移植植入物、抗生素骨水泥）
  • 抗菌導管（泌尿導管、心血管導管、其他導管、其他產品）

第 6 章：全球藥物器材組合產品市場分析：依應用分類

  • 概述：按應用
  • 歷史與預測資料分析：按應用分類
  • 心血管疾病
  • 糖尿病
  • 呼吸系統的問題
  • 癌症治療
  • 抗菌應用
  • 其他

第 7 章：全球藥物器材組合產品市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院和診所
  • 門診手術中心
  • 家庭護理設置
  • 其他

第 8 章：全球藥物器材組合產品市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：藥物器材組合產品公司的競爭格局

  • 藥物器材組合產品市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AbbVie Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Alcon Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bausch Health Companies Inc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Baxter International Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bayer AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Becton, Dickinson And Company
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teva Pharmaceutical Industries Ltd
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boston Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GlaxoSmithKline Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Johnson & Johnson
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Kaleo Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medtronic Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novartis AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sinomed
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Smith & Nephew Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teleflex Incorporated
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114874

The global demand for Drug Device Combination Products Market is presumed to reach the market size of nearly USD 296.74 Billion by 2032 from USD 144.66 Billion in 2023 with a CAGR of 8.31% under the study period 2024-2032.

Drug device combination products are medical products that combine a drug or biologic substance with a medical device to deliver therapeutic benefits or perform specific treatment functions. These products are designed to provide targeted drug delivery, enhance drug efficacy, improve patient compliance, or enable novel treatment modalities that may not be achievable with conventional drug formulations or medical devices alone. These products encompass various healthcare interventions, including drug-eluting stents, insulin pumps, contraceptive implants, and inhalation devices. These innovative products offer potential advantages in precision medicine, personalized therapy, and patient convenience, driving advancements in medical treatment and improving patient outcomes across various therapeutic areas.

MARKET DYNAMICS

The rising demand for tailored medicine and targeted therapies drives the development of innovative drug-device combination products that offer precise drug delivery mechanisms and improved patient compliance. As healthcare providers and patients seek more effective and convenient treatment options, there's a rising interest in combination products that combine pharmaceuticals' therapeutic benefits with medical devices' precision and reliability. Additionally, drug formulation technologies and device design advancements enable the development of novel combination products for numerous medical conditions, ranging from chronic diseases to acute conditions. Moreover, regulatory initiatives and guidelines governing combination products, such as the FDA's Combination Product Policy and the EU's Medical Device Regulation (MDR), provide a framework for manufacturers to navigate the complex regulatory landscape and bring innovative products to market.

Furthermore, strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions drive innovation and drug-device combination products market expansion, fostering the development of new drug-device combination products across therapeutic areas. Increasing healthcare expenditure and reimbursement support for combination products incentivize investment in research and development, further driving drug-device combination products market growth. However, regulatory hurdles and complexities associated with combination product development and reimbursement challenges may challenge the drug device combination products market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Device Combination Products. The growth and trends of Drug Device Combination Products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Device Combination Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps)
  • Photodynamic Therapy
  • Wound Care Combination Product
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons)
  • Nebulizers
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs))
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products)

By Application

  • Cardiovascular Disorders
  • Diabetes
  • Respiratory Problems
  • Cancer Treatment
  • Antimicrobial Application
  • Other

By End-use

  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Device Combination Products market include Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch Health Companies Inc, Baxter International Inc., Bayer AG, Becton, Dickinson And Company, Boston Scientific Corporation, GlaxoSmithKline Plc, Johnson & Johnson, Kaleo Inc., Medtronic Plc, Novartis AG, Sinomed, Smith & Nephew Plc, Teleflex Incorporated, Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DRUG DEVICE COMBINATION PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Historic and Forecast Sales By Regions
  • 5.4. Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Historic and Forecast Sales By Regions
  • 5.5. Photodynamic Therapy Historic and Forecast Sales By Regions
  • 5.6. Wound Care Combination Product Historic and Forecast Sales By Regions
  • 5.7. Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Historic and Forecast Sales By Regions
  • 5.8. Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Historic and Forecast Sales By Regions
  • 5.9. Nebulizers Historic and Forecast Sales By Regions
  • 5.10. Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Historic and Forecast Sales By Regions
  • 5.11. Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Historic and Forecast Sales By Regions
  • 5.12. Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Historic and Forecast Sales By Regions
  • 5.13. Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Historic and Forecast Sales By Regions

6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 6.4. Diabetes Historic and Forecast Sales By Regions
  • 6.5. Respiratory Problems Historic and Forecast Sales By Regions
  • 6.6. Cancer Treatment Historic and Forecast Sales By Regions
  • 6.7. Antimicrobial Application Historic and Forecast Sales By Regions
  • 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.5. Home Care Settings Historic and Forecast Sales By Regions
  • 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION PRODUCTS COMPANIES

  • 9.1. Drug Device Combination Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF DRUG DEVICE COMBINATION PRODUCTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. AbbVie Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Alcon Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bausch Health Companies Inc
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Baxter International Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Bayer AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Becton, Dickinson And Company
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Teva Pharmaceutical Industries Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Boston Scientific Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GlaxoSmithKline Plc
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Johnson & Johnson
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Kaleo Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Medtronic Plc
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Novartis AG
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Sinomed
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments
  • 10.18. Smith & Nephew Plc
    • 10.18.1 Company Overview
    • 10.18.2 Company Revenue
    • 10.18.3 Products
    • 10.18.4 Recent Developments
  • 10.19. Teleflex Incorporated
    • 10.19.1 Company Overview
    • 10.19.2 Company Revenue
    • 10.19.3 Products
    • 10.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
  • Photodynamic Therapy Market Sales By Geography (USD MN)
  • Wound Care Combination Product Market Sales By Geography (USD MN)
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
  • Nebulizers Market Sales By Geography (USD MN)
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Respiratory Problems Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Antimicrobial Application Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Drug Device Combination Products Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Drug Device Combination Products Report
  • Market Research Process
  • Market Research Methodology
  • Global Drug Device Combination Products Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
  • Photodynamic Therapy Market Sales By Geography (USD MN)
  • Wound Care Combination Product Market Sales By Geography (USD MN)
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
  • Nebulizers Market Sales By Geography (USD MN)
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Respiratory Problems Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Antimicrobial Application Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.